Work

Phase I/II trial of the oral regimen ixazomib, pomalidomide, and dexamethasone in relapsed/refractory multiple myeloma

Year: 2017

Type: article

Study design: Clinical Trial

Source: Leukemia

DOI: 10.1038/leu.2017.352

Authors: A Krishnan, P Kapoor, J M Palmer, N-C Tsai, S Kumar, S Lonial, M Htut, C Karanes, N Nathwani, M Rosenzweig, F Sahebi, G Somlo, L Duarte, J F Sanchez, D Auclair, S J Forman, J G Berdeja

Institutions: City Of Hope National Medical Center, City of Hope, Mayo Clinic, Emory University, Winship Cancer Institute, Kaiser Permanente, Multiple Myeloma Research Foundation, Sarah Cannon

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4241749763

FWCI: 1.446

Cites:

Cited by: 9

Related to: 10